Loading insider details...
Beta
Latest Form 4 (Feb 23, 2026): Grant/Award of 270,000 CNTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 23, 2026 | Context Therapeutics Inc. (CNTX) | Grant/Award | 270,000 | n/a |
| Jun 10, 2025 | Context Therapeutics Inc. (CNTX) | Purchase | 20,000 | $11.5K |
| Feb 14, 2025 | Context Therapeutics Inc. (CNTX) | Grant/Award | 349,900 | n/a |
| Mar 22, 2024 | Context Therapeutics Inc. (CNTX) | Grant/Award | 153,515 | n/a |
| Feb 14, 2023 | Context Therapeutics Inc. (CNTX) | Grant/Award | 151,505 | n/a |
| Dec 12, 2022 | Context Therapeutics Inc. (CNTX) | Purchase | 6,000 | $5.1K |
| Feb 25, 2022 | Context Therapeutics Inc. (CNTX) | Grant/Award | 107,870 | n/a |
| Oct 25, 2021 | Context Therapeutics Inc. (CNTX) | Purchase | 3,000 | $15.0K |